EMONO for the Treatment of Peripheral Neuropathic Pain
Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
To assess the effect of 3 consecutive days of one-hour administration of Nitrous Oxide/Oxygen
50%/50% (EMONO) versus placebo as Oxygen/Nitrogen 22%/78% (synthetic medical air), in add-on
therapy to chronic analgesic treatments, on average pain intensity in patients with chronic
peripheral neuropathic pain. A total of 250 randomised patients to be included in all the
participating centres, i.e., 125 randomised patients in each of the 2 study groups treatments